Tokyo, Aug. 5 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062462) titled 'An Exploratory Study on Blood microRNAs Following Chocolate Ingestion' on Aug. 4.
Study Type:
Observational
Primary Sponsor:
Institute - Hokkaido Information University
Condition:
Condition - Healthy adult
Classification by malignancy - Others
Genomic information - YES
Objective:
Narrative objectives1 - This study aims to evaluate the relationship between serum microRNAs, body composition, and blood biomarkers in men and women aged 60 to 79 years following 16 weeks of continuous chocolate ingestion.
No new interventions will be conducted in this study; stored serum samples and clinical data previously collected in the UMIN000054576 study will be utilized.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 60
years-old
Gender - Male and Female
Key inclusion criteria - 1. Subjects randomized to the non-ingestion group or the chocolate intervention group within the efficacy analysis population of UMIN000054576.
2. Subjects who agree to the secondary use of samples and data collected in UMIN000054576.
Key exclusion criteria - Subjects who decline the use of their samples or data for this study.
Target Size - 148
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2026 Year 07 Month 27 Day
Date of IRB - 2026 Year 07 Month 27 Day
Anticipated trial start date - 2026 Year 09 Month 07 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071465
Disclaimer: Curated by HT Syndication.
